Literature DB >> 12867419

Kinetics of amyloid beta-protein degradation determined by novel fluorescence- and fluorescence polarization-based assays.

Malcolm A Leissring1, Alice Lu, Margaret M Condron, David B Teplow, Ross L Stein, Wesley Farris, Dennis J Selkoe.   

Abstract

Proteases that degrade the amyloid beta-protein (Abeta) are important regulators of brain Abeta levels in health and in Alzheimer's disease, yet few practical methods exist to study their detailed kinetics. Here, we describe robust and quantitative Abeta degradation assays based on the novel substrate, fluorescein-Abeta-(1-40)-Lys-biotin (FAbetaB). Liquid chromatography/mass spectrometric analysis shows that FAbetaB is hydrolyzed at closely similar sites as wild-type Abeta by neprilysin and insulin-degrading enzyme, the two most widely studied Abeta-degrading proteases. The derivatized peptide is an avid substrate and is suitable for use with biological samples and in high throughput compound screening. The assays we have developed are easily implemented and are particularly useful for the generation of quantitative kinetic data, as we demonstrate by determining the kinetic parameters of FAbetaB degradation by several Abeta-degrading proteases, including plasmin, which has not previously been characterized. The use of these assays should yield additional new insights into the biology of Abeta-degrading proteases and facilitate the identification of activators and inhibitors of such enzymes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867419     DOI: 10.1074/jbc.M305627200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Inhibition of Insulin-Degrading Enzyme Does Not Increase Islet Amyloid Deposition in Vitro.

Authors:  Meghan F Hogan; Daniel T Meier; Sakeneh Zraika; Andrew T Templin; Mahnaz Mellati; Rebecca L Hull; Malcolm A Leissring; Steven E Kahn
Journal:  Endocrinology       Date:  2016-07-12       Impact factor: 4.736

2.  Catalytic Mechanism of Amyloid-β Peptide Degradation by Insulin Degrading Enzyme: Insights from Quantum Mechanics and Molecular Mechanics Style Møller-Plesset Second Order Perturbation Theory Calculation.

Authors:  Rui Lai; Wei-Jen Tang; Hui Li
Journal:  J Chem Inf Model       Date:  2018-09-06       Impact factor: 4.956

3.  Cell-permeable, small-molecule activators of the insulin-degrading enzyme.

Authors:  Sayali S Kukday; Surya P Manandhar; Marissa C Ludley; Mary E Burriss; Benjamin J Alper; Walter K Schmidt
Journal:  J Biomol Screen       Date:  2012-06-26

4.  Structures of soluble rabbit neprilysin complexed with phosphoramidon or thiorphan.

Authors:  Shaunivan L Labiuk; Jurgen Sygusch; Pawel Grochulski
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-05-10       Impact factor: 1.056

5.  A capillary electrophoresis method for evaluation of Abeta proteolysis in vitro.

Authors:  Benjamin J Alper; Walter K Schmidt
Journal:  J Neurosci Methods       Date:  2008-11-21       Impact factor: 2.390

6.  Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme.

Authors:  Enrico Malito; Luis A Ralat; Marika Manolopoulou; Julie L Tsay; Natasha L Wadlington; Wei-Jen Tang
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

7.  Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin.

Authors:  Malcolm A Leissring; Enrico Malito; Sabrine Hedouin; Lael Reinstatler; Tomoko Sahara; Samer O Abdul-Hay; Shakeel Choudhry; Ghulam M Maharvi; Abdul H Fauq; Malwina Huzarska; Philip S May; Sungwoon Choi; Todd P Logan; Benjamin E Turk; Lewis C Cantley; Marika Manolopoulou; Wei-Jen Tang; Ross L Stein; Gregory D Cuny; Dennis J Selkoe
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

8.  Molecular basis for the thiol sensitivity of insulin-degrading enzyme.

Authors:  Marie Neant-Fery; Rubén D Garcia-Ordoñez; Todd P Logan; Dennis J Selkoe; Lilin Li; Lael Reinstatler; Malcolm A Leissring
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-08       Impact factor: 11.205

9.  Small-molecule activators of insulin-degrading enzyme discovered through high-throughput compound screening.

Authors:  Christelle Cabrol; Malwina A Huzarska; Christopher Dinolfo; Maria C Rodriguez; Lael Reinstatler; Jake Ni; Li-An Yeh; Gregory D Cuny; Ross L Stein; Dennis J Selkoe; Malcolm A Leissring
Journal:  PLoS One       Date:  2009-04-22       Impact factor: 3.240

10.  Insulin-degrading enzyme is exported via an unconventional protein secretion pathway.

Authors:  Ji Zhao; Lilin Li; Malcolm A Leissring
Journal:  Mol Neurodegener       Date:  2009-01-14       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.